CD4 and infection: Notably, potent antagonism of SERINC5 enhanced the infectivity of virions produced in pre-activated CD4+ T cells only 2- to 3-fold (Fig 8) but had up to 10-fold effects when PBMCs were stimulated several days after infection (Fig 9).